This inventor holds 5 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents and 3 EPO patents. Top assignees: Katholieke Universiteit Leuven, Vib Vzw, Vrije Universiteit Brussel. Active years: 2013-2022.
Company Filing History:
5 out of 630 
5 out of 237 
3 out of 190 
Years Active: 2013-2022
Title: Lujia Zhou: Innovator in Tauopathy Treatment
Introduction
Lujia Zhou is a prominent inventor based in Leuven, Belgium. He has made significant contributions to the field of medical research, particularly in the treatment of tauopathies. With a total of 5 patents, Zhou's work focuses on innovative approaches to combat neurodegenerative diseases.
Latest Patents
One of Zhou's latest patents involves targeting synaptogyrin-3 in tauopathy treatment. This invention identifies synaptogyrin-3 as a crucial target for treating or inhibiting the progression of tauopathies and their symptoms. The patent also outlines methods for identifying or screening inhibitors of synaptogyrin-3. Another notable patent describes single domain antibodies capable of modulating BACE activity. These antibodies, derived from camelids, specifically bind to BACE1 and inhibit its activity. This innovation holds promise for research and medical applications, particularly in the treatment of Alzheimer's disease.
Career Highlights
Throughout his career, Lujia Zhou has worked with esteemed organizations such as Vib Vzw and Katholieke Universiteit Leuven, also known as KU Leuven R&D. His research has significantly advanced the understanding of tauopathies and potential therapeutic interventions.
Collaborations
Zhou has collaborated with notable colleagues, including Bart De Strooper and Els Marjaux. These partnerships have further enriched his research and contributed to the development of innovative solutions in the field.
Conclusion
Lujia Zhou's contributions to medical research, particularly in the treatment of tauopathies, highlight his role as an influential inventor. His innovative patents and collaborations continue to pave the way for advancements in neurodegenerative disease treatment.